Your browser doesn't support javascript.
loading
SARS-CoV-2 infection prevalence and associated factors among primary healthcare workers in France after the third COVID-19 wave.
Pouquet, Marie; Decarreaux, Dorine; Di Domenico, Laura; Sabbatini, Chiara E; Prévot-Monsacre, Pol; Fourié, Toscane; Villarroel, Paola Mariela Saba; Priet, Stephane; Blanché, Hélène; Sebaoun, Jean-Marc; Deleuze, Jean-François; Turbelin, Clément; Rossignol, Louise; Werner, Andréas; Kochert, Fabienne; Grosgogeat, Brigitte; Rabiega, Pascaline; Laupie, Julien; Abraham, Nathalie; Noël, Harold; van der Werf, Sylvie; Colizza, Vittoria; Carrat, Fabrice; Charrel, Remi; de Lamballerie, Xavier; Blanchon, Thierry; Falchi, Alessandra.
Afiliação
  • Pouquet M; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique (IPLESP), 75012, Paris, France. marie.pouquet@iplesp.upmc.fr.
  • Decarreaux D; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique (IPLESP), 75012, Paris, France.
  • Di Domenico L; Laboratoire de Virologie, Université de Corse Pascal Paoli, UR7310 Bioscope, 20250, Corte, France.
  • Sabbatini CE; Unité Des Virus Emergents, Aix Marseille University, IRD 190, INSERM U1207, 13005, Marseille, France.
  • Prévot-Monsacre P; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique (IPLESP), 75012, Paris, France.
  • Fourié T; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique (IPLESP), 75012, Paris, France.
  • Villarroel PMS; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique (IPLESP), 75012, Paris, France.
  • Priet S; Unité Des Virus Emergents, Aix Marseille University, IRD 190, INSERM U1207, 13005, Marseille, France.
  • Blanché H; Unité Des Virus Emergents, Aix Marseille University, IRD 190, INSERM U1207, 13005, Marseille, France.
  • Sebaoun JM; Unité Des Virus Emergents, Aix Marseille University, IRD 190, INSERM U1207, 13005, Marseille, France.
  • Deleuze JF; Fondation Jean Dausset-CEPH, 75010, Paris, France.
  • Turbelin C; Fondation Jean Dausset-CEPH, 75010, Paris, France.
  • Rossignol L; Fondation Jean Dausset-CEPH, 75010, Paris, France.
  • Werner A; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique (IPLESP), 75012, Paris, France.
  • Kochert F; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique (IPLESP), 75012, Paris, France.
  • Grosgogeat B; Association Française de Pédiatrie Ambulatoire (AFPA), Zone de la Fouquetière, 155 Rue Edouard Branly, 44150, Ancenis-Saint-Géréon, France.
  • Rabiega P; Association Française de Pédiatrie Ambulatoire (AFPA), Zone de la Fouquetière, 155 Rue Edouard Branly, 44150, Ancenis-Saint-Géréon, France.
  • Laupie J; Faculté d'Odontologie, Université Claude Bernard Lyon 1, Université de Lyon, 69000, Lyon, France.
  • Abraham N; Laboratoire des Multimatériaux et Interfaces, UMR CNRS 5615, Université Claude Bernard Lyon 1, Université de Lyon, 69000, Lyon, France.
  • Noël H; Réseau ReCOL, Association Dentaire Française, 75000, Paris, France.
  • van der Werf S; Service d'Odontologie, Hospices Civils de Lyon, 69007, Lyon, France.
  • Colizza V; IQVIA, Réseau de Pharmaciens, 75000, Paris, France.
  • Carrat F; Réseau ReCOL, Association Dentaire Française, 75000, Paris, France.
  • Charrel R; IQVIA, Réseau de Pharmaciens, 75000, Paris, France.
  • de Lamballerie X; Infectious Diseases Division, Santé Publique France, 94410, Saint Maurice, France.
  • Blanchon T; Institut Pasteur, Université Paris Cité, CNRS UMR3569, Molecular Genetics of RNA Viruses Unit, 75015, Paris, France.
  • Falchi A; Institut Pasteur, Université Paris Cité, National Reference Center for Respiratory Viruses, 75015, Paris, France.
Sci Rep ; 14(1): 5418, 2024 03 05.
Article em En | MEDLINE | ID: mdl-38443618
ABSTRACT
Data on the SARS-CoV-2 infection among primary health care workers (PHCWs) are scarce but essential to reflect on policy regarding prevention and control measures. We assessed the prevalence of PHCWs who have been infected by SARS-CoV-2 in comparison with modeling from the general population in metropolitan France, and associated factors. A cross-sectional study was conducted among general practitioners (GPs), pediatricians, dental and pharmacy workers in primary care between May and August 2021. Participants volunteered to provide a dried-blood spot for SARS-CoV-2 antibody assessment and completed a questionnaire. The primary outcome was defined as the detection of infection-induced antibodies (anti-nucleocapsid IgG, and for non-vaccinees anti-Spike IgG and neutralizing antibodies) or previous self-reported infection (positive RT-qPCR or antigenic test, or positive ELISA test before vaccination). Estimates were adjusted using weights for representativeness and compared with prediction from the general population. Poisson regressions were used to quantify associated factors. The analysis included 1612 PHCWs. Weighted prevalences were 31.7% (95% CI 27.5-36.0) for GPs, 28.7% (95% CI 24.4-33.0) for pediatricians, 25.2% (95% CI 20.6-31.0) for dentists, and 25.5% (95% CI 18.2-34.0) for pharmacists. Estimates were compatible with model predictions for the general population. PHCWs more likely to be infected were GPs compared to pharmacist assistants (adjusted prevalence ratio [aPR] = 2.26; CI 95% 1.01-5.07), those living in Île-de-France (aPR = 1.53; CI 95% 1.14-2.05), South-East (aPR = 1.57; CI 95% 1.19-2.08), North-East (aPR = 1.81; CI 95% 1.38-2.37), and those having an unprotected contact with a COVID-19 case within the household (aPR = 1.48; CI 95% 1.22-1.80). Occupational factors were not associated with infection. In conclusion, the risk of SARS-CoV-2 exposure for PHCWs was more likely to have occurred in the community rather than at their workplace.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Clínicos Gerais / COVID-19 Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Clínicos Gerais / COVID-19 Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2024 Tipo de documento: Article